Biomedical Bonding - A paradigm shift in bone restoration surgeries
BOARD of directors
Michael Malkoch
CEO & Founder
Professor and a self-made entrepreneur with extensive experience in start-up companies taking cuttingedge nanomaterials from the research stage to commercialisation and global sales. Has a broad understanding of scaling innovations from micrograms to kilograms in an array of sectors ranging from diagnostics and MedTech, to Pharma and semiconductor industries. His track record includes striking deals with large enterprises including Medtech and big Pharma.
Rami Elias
Board Member & Chief Medical Officer
Highly skilled orthopaedic surgeon specialising in sports medicine and shoulder & knee arthroscopies; including cuff repair, ligament reconstructions and patella stabilisation. He is also the director and founder of Specialistcenter Scandinavia, Specialistcenter Malmö and Specialistcenter Uppsala, 3 private hospitals with ability to conduct arthroplasty, foot, hand, shoulder and knee surgery. As CMO, Rami is responsible for the surgical usability of BMB’s product platform Bonevolent™, with emphasis on outreach to the orthopaedic community and implementation of clinical indications.
Catrin Molund
Board Member
Catrin Molund has a degree from Uppsala University with over 20 years of experience in the pharmaceutical and medical device industry from companies such as Senzime, Orexo, Phadia, Amersham Biosciences and Pyrosequencing. Positions include roles as VP Global Marketing & Business Development, IT Director, International Marketing and Project Management. She has a track record of heading marketing strategies, global product launches and international sales. Her experience also covers design and implementation of licensing and distribution agreements as well as business development strategies.
Daniel Malkoch
Board Member and Chief Communication Officer
Daniel has a chemical engineering background from KTH Royal Institute of Technology and multi-year’s experience in product marketing and as a sales manager of technical products with exceptional records. His track record includes business development of a SME to a major player on the national market and increasing annual revenues from €0.2M to €5M by product sales optimization and securing important contracts. His best asset is to build business and sales strategies that outperform competitors. He has a long experience in negotiating with company boards within technical products. As CCO at BMB, Daniel holds the responsibility for marketing, communication and sales strategies.